🟢 At a Glance:
- 🎯Director: John B. Bode
- 🧾Form Type: SEC Form 4 (filed May 30, 2025)
- 🗓️Grant Date: May 29, 2025
- đź’°Transaction:30,000 stock optionsawarded
- ⚙️Exercise Price: $8.62 (closing price on grant day)
- đź’¸Cost to Acquire: $0 (compensation-based grant)
- 🗓️Expiry: May 28, 2035
đź“ś Details of the Transaction
| 🧪 Detail | 💡 Description |
|---|---|
| Company | Zevra Therapeutics Inc. (ZVRA) |
| Reporting Person | John B. Bode (Director) |
| Type of Security | Stock Option (right to buy common stock) |
| Options Granted | 30,000 shares |
| Exercise Price | $8.62/share |
| Vesting | 100% vests by: |
- 1 year from grant, OR
- 1 day before next AGM, OR
- Immediately upon change of control ||Form Type| SEC Form 4 – Insider Reporting ||Ownership Type| Direct (D) |
To Read Full 16 Point ArticleBecome a member